Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (81)

« Back to Publications

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection

Hou MM. et al, (2025), Nature Communications, 16

Mixed-methods study assessing the acceptability and feasibility of Human Challenge Studies for Disease X in Healthy UK Adults in a SARS-CoV-2 pandemic setting

Emary KRW. et al, (2025), BMJ Public Health, 3, e003096 - e003096

Gonorrhoea: rising cases and antimicrobial resistance

Davis P. et al, (2025), BMJ, 389, r1001 - r1001

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men

Firth C. et al, (2025), Vaccine, 54, 127013 - 127013

An experimental model of clinical immunity for human malaria

Hou MM. et al, (2025)

Roles and responsibilities of participants, researchers, and the media in the communication of vaccine trials: Experience from the United Kingdom's first COVID-19 vaccine trial

Patrick-Smith M. et al, (2024), Vaccine, 42, 126391 - 126391

Preliminary evidence supporting use of UK consensus definitions for necrotising otitis externa

Takata J. et al, (2024), Clinical Infection in Practice, 24, 100387 - 100387

Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

Silk SE. et al, (2023), Med, 4, 668 - 686.e7

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

Hou MM. et al, (2023), Science Translational Medicine, 15

Co-producing Human and Animal Experimental Subjects: Exploring the Views of UK COVID-19 Vaccine Trial Participants on Animal Testing

Vanderslott S. et al, (2023), Science, Technology, & Human Values, 48, 909 - 937

Systematic review of the diagnosis and management of necrotising otitis externa: Highlighting the need for high‐quality research

Takata J. et al, (2023), Clinical Otolaryngology, 48, 381 - 394

Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults

Silk SE. et al, (2023)

Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria

Odera DO. et al, (2023), Science Translational Medicine, 15

UK consensus definitions for necrotising otitis externa: a Delphi study

Hodgson SH. et al, (2023), BMJ Open, 13, e061349 - e061349

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines

Thomas TM. et al, (2023), Human Vaccines & Immunotherapeutics, 19

Load More

1
2
3
4
5
6